Elite Pharma - Delisted OTC Stock
Elite Pharma is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Elite Pharma was actively traded.
Valuation
Check how we calculate scores
Elite Pharma Risk Profiles
Risk Adjusted Performance | 0.0708 | |||
Jensen Alpha | 0.9731 | |||
Total Risk Alpha | (0.36) | |||
Treynor Ratio | (1.02) |
Elite Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Elite Pharma otc stock to make a market-neutral strategy. Peer analysis of Elite Pharma could also be used in its relative valuation, which is a method of valuing Elite Pharma by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Elite Pharma Corporate Management
Elected by the shareholders, the Elite Pharma's board of directors comprises two types of representatives: Elite Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elite. The board's role is to monitor Elite Pharma's management team and ensure that shareholders' interests are well served. Elite Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elite Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Douglas Plassche | Executive VP of Operations | Profile | |
Dianne Will | VP of Investor Relations and Corporate Affairs | Profile | |
Sophy Abraham | Head Affairs | Profile | |
Robert Chen | S CFO | Profile | |
JD MBA | VP Legal | Profile | |
Kirko Kirkov | Chief Officer | Profile |
Still Interested in Elite Pharma?
Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Elite OTC Stock
If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |